Immunohistochemical Analysis of Human Equilibrative Nucleoside Transporter-1 (hENT1) Predicts Survival in Resected Pancreatic Cancer Patients Treated with Adjuvant Gemcitabine Monotherapy

By Morinaga Soichiro   Nakamura Yoshiyasu   Watanabe Takuo   Mikayama Hiroshi   Tamagawa Hiroshi   Yamamoto Naoto   Shiozawa Manabu   Akaike Makoto   Ohkawa Shinnichi   Kameda Yoichi   Miyagi Yohei  

Annals of Surgical Oncology, Vol. 19, Iss. 3, 2012-07 ,pp. : 558-564

Springer Publishing Company

Access to resources Recommend Favorite

Combined Analysis of Dihydropyrimidine Dehydrogenase and Human Equilibrative Nucleoside Transporter 1 Expression Predicts Survival of Pancreatic Carcinoma Patients Treated with Adjuvant Gemcitabine Plus S-1 Chemotherapy after Surgical Resection

By Kondo Naru   Murakami Yoshiaki   Uemura Kenichiro   Sudo Takeshi   Hashimoto Yasushi   Nakashima Akira   Sueda Taijiro  

Annals of Surgical Oncology, Vol. 19, Iss. 3, 2012-07 ,pp. : 646-655

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Nucleoside Transport in the Antineoplastic Activity of Purine Nucleoside Chemotherapeutic Agents

By  

Current Cancer Therapy Reviews, Vol. 4, Iss. 1, 2008-02 ,pp. : 21-30

Bentham Science Publishers

Access to resources Recommend Favorite

Down-regulation of lipids transporter ABCA1 increases the cytotoxicity of Nitidine

By Iwasaki Hironori   Okabe Takafumi   Takara Kensaku   Yoshida Yasuhiko   Hanashiro Kaoru   Oku Hirosuke  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 5, 2010-10 ,pp. : 953-959

Springer Publishing Company

Access to resources Recommend Favorite

Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells

By Catania Angela   Barrajón-Catalán Enrique   Nicolosi Silvia   Cicirata Federico   Micol Vicente  

Breast Cancer Research and Treatment, Vol. 141, Iss. 1, 2013-08 ,pp. : 55-65

Springer Publishing Company

Access to resources Recommend Favorite